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NMDA receptors promote neuronal survival but
also cause cell degeneration and neuron loss.
The mechanisms underlying these opposite
effects on neuronal fate are unknown. Whole-
genome expression profiling revealed that NMDA
receptor signaling is decoded at the genomic
level through activation of two distinct, largely
nonoverlapping gene-expression programs.
The location of the NMDA receptor activated
specifies the transcriptional response: synaptic
NMDA receptors induce a coordinate upregula-
tion of newly identified pro-survival genes and
downregulation of pro-death genes. Extrasy-
naptic NMDA receptors fail to activate this neu-
roprotective program, but instead induce ex-
pression of Clca1, a putative calcium-activated
chloride channel that kills neurons. These re-
sults help explain the opposing roles of synaptic
and extrasynaptic NMDA receptors on neuronal
fate. They also demonstrate that the survival
function is implemented in neurons through a
multicomponent system of functionally related
genes, whose coordinate expression is con-
trolled by specific calcium signal initiation sites.
INTRODUCTION
A single neurotransmitter receptor, the N-methyl-D-aspar-
tate (NMDA)-type of glutamate receptors, controls both
the physiology and pathology of neurons (Hardingham
and Bading, 2003). NMDA receptors promote neuronal
survival, trigger changes in synaptic efficacy and neuronal
network behavior, and are central to the process that leads
to information storage and memory formation in the brain
(Hardingham and Bading, 2003; Milner et al., 1998). How-
ever, the same receptor can also kill neurons: NMDANreceptor activation is the primary cause of neuronal cell
death associated with cerebral ischemia, head injury,
and seizure. Moreover, NMDA receptors have been impli-
cated in the etiology of several neurodegenerative disor-
ders, including Huntington’s disease and Alzheimer’s dis-
ease (Hardingham and Bading, 2003; Choi, 1992; Lipton
and Rosenberg, 1994; Bossy-Wetzel et al., 2004).
NMDA receptors are calcium-permeable ion channels
that affect intracellular biochemical processes through
the activation of calcium signaling pathways (Hardingham
and Bading, 2003). It has been suggested that differences
in the degree of receptor activation (giving rise to different
size calcium transients) account for the directly opposing
effects on cell fate, with low or moderate stimulation of the
receptor promoting survival and overactivation inflicting
neuronal damage (Hardingham and Bading, 2003; Choi,
1992; Lipton and Rosenberg, 1994; Bossy-Wetzel et al.,
2004). However, other experiments indicate that survival-
promoting signals derive from NMDA receptors that are
localized to synaptic contact, whereas cell-death path-
ways are triggered by extrasynaptic NMDA receptors,
suggesting that receptor localization rather than its degree
of activation determines the cellular consequences (Hardi-
ngham et al., 2002). In addition to the controversy about
the precise nature of the early signaling events that de-
cides the neuronal fate, the downstream machinery that
guides neurons toward survival or death is unexplored.
Because neuronal calcium transients activate signaling
pathways (such as the ERK-MAP kinase and the CaM ki-
nases pathways) that transduce information to the cell
nucleus and modulate the activity of transcription factors
(Bading and Greenberg, 1991; Bading et al., 1993; Bading,
2000; West et al., 2001), we reasoned that differences in
genomic responses may account for the differences in
the biological outcome. The method of choice to obtain
a comprehensive picture of the transcriptome involves
the use of DNA microarrays (DeRisi et al., 1997; Hughes
et al., 2000). This technology has helped identify functional
genetic modules in inflammatory responses (Calvano
et al., 2005) and uncovered signature patterns of gene ex-
pression that, for example in cancer or diabetes, correlateeuron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 549
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sponses (Lamb et al., 2003; Rhodes and Chinnaiyan,
2005; Segal et al., 2005; Mootha et al., 2003). Whole-
genome profiling of hippocampal neurons revealed an
unexpected difference in the transcriptional responses
triggered by calcium flux through synaptic versus extrasy-
naptic NMDA receptors. The decoding of NMDA receptor
signaling uncovered gene programs for neuroprotection
and cell death that explain at the genomic level the oppos-
ing roles of synaptic and extrasynaptic NMDA receptors
on cell fate.
RESULTS
The Type of Electrical Stimulation Specifies
the Transcriptional Responses
Whole-genome transcriptional profiling was done using
cultured hippocampal neurons derived from newborn
mice that, after a culturing period of 10–12 days, form an
elaborate and highly interconnected neuronal network.
We focused on two stimulation protocols to electrically
activate the neurons. One protocol leads to induction of
bursts of action potential (AP) firing, which induces a
long-lasting, transcription-dependent form of synaptic
plasticity in the network (Arnold et al., 2005) and activates
a robust neuronal survival program (Hardingham et al.,
2002; Papadia et al., 2005); the second stimulation para-
digm was bath-applied glutamate that can initiate cell-
death pathways (Hardingham et al., 2002; see below). To
trigger bursts of AP firing, we take advantage of the pres-
ence in the network of inhibitory (GABAergic) interneurons.
GABAergic interneurons impose a tonic inhibition onto the
network through activating GABAA receptors. Removal of
GABAAergic inhibition with the GABAA receptor antagonist
bicuculline results in the firing of bursts of APs (Hardi-
ngham et al., 2002; Arnold et al., 2005); this activates cal-
cium entry through synaptic NMDA receptors, generates
calcium transients in the cytoplasm and the nucleus, and
stimulates expression of several CREB-regulated genes,
including c-fos and brain-derived neurotrophic factor
(Bdnf) (Hardingham et al., 2001, 2002). Changes in gene
expression were assessed at 2 and 4 hr after exposure to
bicuculline. Bath application of glutamate also activates
calcium entry through NMDA receptors (Hardingham
et al., 1999, 2002; Bading et al., 1995), but in contrast to
the AP bursting, calcium enters the neurons also through
extrasynaptic NMDA receptors (Hardingham et al., 2002).
Glutamate treatment evokes global calcium transients
and stimulates gene expression mediated, for example,
by the serum response element (SRE) or by stimulating the
coactivator CREB-binding protein (CBP) (Bading et al.,
1993; Hardingham et al., 1999); it differs from bicuculline-
induced AP bursting inasmuch as it triggers a CREB
shut-off pathway (Hardingham et al., 2002; Sala et al.,
2000). Glutamate stimulation of extrasynaptic NMDA re-
ceptors can also initiate cell-death pathways, which at
high glutamate concentrations leads to failure of mito-550 Neuron 53, 549–562, February 15, 2007 ª2007 Elsevier Incchondrial functions resulting in acute necrosis (Hardi-
ngham et al., 2002).
For the transcriptional profiling, we used a low concen-
tration of glutamate (20 mM), which does trigger CREB
shut off but does not cause acute necrotic cell death
(data not shown). Changes in gene expression were as-
sessed at 2 and 4 hr after exposure to glutamate. To iden-
tify genes controlled by NMDA receptor activation, the
stimulations were done in the presence of the NMDA
receptor blockers MK-801 and APV. MK-801 is a noncom-
petitive antagonist (Wong et al., 1986) and was chosen
in those experiments in which synaptic NMDA receptors
were activated by AP bursting (Hardingham et al., 2001).
APV, a competitive NMDA receptor antagonist, was used
to inhibit NMDA receptor stimulation following bath-
glutamate application (Bading et al., 1993, 1995). For all
experiments, the Affymetrix GeneChip Mouse Expression
Set 430 (MOE 430A and MOE 430B) was used, which
allows analysis of a total of 45,101 probe sets representing
genes and ESTs belonging to 20,283 UniGene clusters
(according to annotations from Affymetrix of July 12,
2006). Probe sets were classified as ‘‘upregulated’’ or
‘‘downregulated’’ if, compared to control, the sample
mean of expression at a given time point is larger or
smaller, respectively, by a factor of at least 1.5 (p% 0.025,
two-tailed Welch t test). A 1.5-fold change was chosen as
the threshold because a comparison of gene-expression
data of known activity-regulated genes (i.e., c-fos and
Bdnf) and newly identified activity-regulated genes ob-
tained with either microarrays or quantitative reverse
transcriptase (QRT)-PCR revealed that the microarray
analysis underestimates the fold differences in gene ex-
pression (see Figure 4 and data not shown; Irizarry et al.,
2003). Thus, by using a threshold of 1.5-fold for the micro-
array analysis, we are filtering out genes that are likely to
undergo signal-induced changes in their expression that
are in the range of at least 2- to 3-fold.
For each stimulation paradigm, we obtained lists of up-
regulated and downregulated probes sets. We identified
478 unique genes (625 probe sets) that were induced and
399 unique genes (435 probe sets) that were repressed
following bicuculline-induced AP bursting. The number
of glutamate-regulated genes (induced 106 unique genes
[120 probe sets]; repressed 51 unique genes [52 probe
sets]) was slightly lower. A color-coded map, which
provides an overview of all electrical activity-regulated
unique genes (Figure 1), illustrates that many genes were
induced or repressed specifically with one stimulation par-
adigm. Table S1 (see the Supplemental Data available
with this article online) contains all genes regulated by
AP bursting and/or bath-glutamate treatment. A compar-
ison of the genes identified in this study with the genes
identified in a study by Hong et al. (2004) revealed very lim-
ited overlap. This may be primarily due to the differences
in the time points after stimulation at which gene expres-
sion was analyzed but may also result from differences
in the methods, the stimulation paradigms, and cell types
used..
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and Extrasynaptic NMDA Receptors Target
Different Gene Pools
We found that only 47 genes (i.e., 10%) out of 478 AP-
bursting-induced genes were also induced by bath-gluta-
mate treatment (Figure 2A). Similarly, 53 genes (i.e., 50%)
out of 106 bath-glutamate-induced genes were also in-
duced by AP bursting (Figure 2C). Although expression
of many genes, which were induced specifically by one
paradigm, changed only moderately (between 1.5- and
2-fold changes based on microarray analysis; see Figures
2A and 2C), for several dozen genes the differences be-
tween the two stimulation paradigms in terms of fold in-
duction were dramatic. Examples are the genes Btg2
and Atf3, which were dramatically induced by AP bursting
but their expression virtually did not change upon bath-
glutamate treatment (see Figure 4). Even less overlap of
the gene pools was found for activity-dependent repres-
sion. Only ten genes (i.e., 3%) out of 399 AP-bursting-
Figure 1. Color-Coded Map of All Genes Identified as Electri-
cal Activity-Regulated Genes in Hippocampal Neurons
The maximum fold change in expression (induction or repression)
based on Affymetrix microarray analysis at 2 or 4 hr after stimulation
is color coded as indicated; for genes, which are represented with
more than one probe set, only the probe set with the largest absolute
effect is shown. White indicates no change upon stimulation. Genes
within the AP-bursting group are sorted on the basis of their expression
values in a ‘‘descending’’ order, i.e., from the highest levels of induction
at the top (indicated in red colors) to the highest level of repression at
the bottom (indicated in blue colors) of the map. Each box corresponds
to one gene, the position of which within the two maps is identical;
corresponding positions on the map indicate the regulation of a given
gene by AP bursting and bath glutamate. The complete list of all elec-
trical-activity-regulated genes is given in Table S1.Nrepressed genes were also repressed by bath-glutamate
treatment (Figure 2B). Similarly, only ten genes (i.e., 20%)
out of 51 genes downregulated following bath-glutamate
treatment were also repressed by AP bursting (Figure 2D).
The induction (or repression) following AP bursting or
bath-glutamate treatment of a large number of probe
sets was dependent on NMDA receptor activation. The
regulation of a probe set was considered dependent on
NMDA receptor activation if the pharmacological block-
ade of NMDA receptors reduced its induction or repres-
sion at all time points analyzed by at least 50% and if
the expression values with and without NMDA receptor
blockers were found to be different according to a two-
tailed Welch t test (p values% 0.025). For 115 out of 478
genes (i.e., 24%), induction by AP bursting was inhibited
by MK-801 (Figure 2A). In the case of bath-glutamate
treatment, APV inhibited induction of 19 of 106 genes
(18%) (Figure 2C). NMDA receptors were also important
for activity-dependent gene repression. The downregula-
tion of 34 out of 399 genes (in case of AP bursting) and 1
out of 51 (in case of bath-glutamate treatment) was in-
hibited by NMDA receptor blockers (Figures 2B and 2D).
Given the selection criteria used for the microarray data
analysis, calcium entry through NMDA receptors regu-
lates a total of 167 genes (upregulation of 132 genes and
downregulation of 35 genes).
We next investigated the possibility that calcium sig-
naling pathways induced by synaptic and extrasynaptic
NMDA receptors have different gene targets. Synaptic
NMDA receptors are stimulated with the AP-bursting par-
adigm, whereas bath glutamate also activates extrasy-
naptic NMDA receptors. To obtain genes regulated by
synaptic NMDA receptors only, we used the list containing
those AP-bursting-regulated probe sets whose induction
was inhibited by MK-801 and filtered out genes induced
by bath glutamate. This identified 108 genes induced by
synaptic NMDA receptor only (Figure 2A). Among those
genes is a set of survival-promoting genes that mediate
long-lasting neuroprotection afforded by synaptic NMDA
receptors (see below). We also identified, using a similar
procedure, genes regulated by extrasynaptic NMDA re-
ceptors only: genes induced by AP bursting (stimulating
synaptic NMDA receptors) were removed from the list
containing those bath glutamate-regulated genes whose
induction was inhibited by APV. This revealed 11 genes in-
duced by extrasynaptic NMDA receptors only (Figure 2C);
this includes a putative calcium-activated chloride chan-
nel (Clca1) that promotes cell death (Elble and Pauli, 2001)
(see below). The same filtering procedure was applied to
the list of genes repressed by NMDA receptors. This iden-
tified a pool of 34 genes repressed selectively by synaptic
NMDA receptors and one gene repressed selectively
by extrasynaptic NMDA receptors (Figures 2B and 2D).
These results indicate that target-gene induction and re-
pression by calcium signaling pathways is specified by
the localization of the site of calcium signal initiation.
Genes selectively regulated by synaptic NMDA or extrasy-
naptic NMDA receptors are marked in Table S1.euron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 551
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Decoding NMDA Receptor SignalingFigure 2. Transcriptional Responses Depend on the Type of Electrical Stimulation and the Site of Calcium Entry: Synaptic and
Extrasynaptic NMDA Receptors Target Different Gene Pools
(A and B) The number of genes induced (A) and repressed (B) by AP bursting; the regulation of the same pool of genes by bath-glutamate treatment is
also shown. The cake diagrams illustrate the number of genes regulated in an MK-801-sensitive manner and genes regulated by synaptic but not
extrasynaptic NMDA receptors.
(C and D) The number of genes induced (C) and repressed (D) by bath-glutamate treatment; the regulation of the same pool of genes by AP bursting is
also shown. The cake diagrams illustrate the number of genes regulated in an APV-sensitive manner and genes regulated by extrasynaptic but not
synaptic NMDA receptors.Transcription Is Required for Survival
and Cell-Death Programs
We next investigated whether genomic responses are re-
quired for survival and cell-death programs induced by
synaptic and extrasynaptic NMDA receptors, respec-
tively. Activity-dependent survival was induced by a period
of AP bursting stimulating synaptic NMDA receptors (Har-
dingham et al., 2002; Lee et al., 2005; Papadia et al.,
2005). Hippocampal neurons were subsequently chal-
lenged by the withdrawal of growth factors, which induces
apoptosis (Hardingham et al., 2002; Papadia et al., 2005).
Synaptic NMDA receptor-induced survival blocked cell
death induced by growth-factor withdrawal (Figure 3A;
Hardingham et al., 2002; Papadia et al., 2005). This neuro-
protective activity was dependent on gene transcription
and was not generated when the period of AP bursting
was done in the presence of the inhibitor of gene tran-
scription, actinomycin D (Figure 3A). Gene transcription
is also an important factor for glutamate-induced cell552 Neuron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc.death, which had been shown previously in retinal gan-
glion cells (Dreyer et al., 1995). We found that, in hippo-
campal neurons, the increase in cell death triggered by
40 mM glutamate bath application was significantly re-
duced by actinomycin D (Figure 3B). These findings indi-
cate that gene regulation induced by extrasynaptic
NMDA receptors, which initiates death signaling (Hardi-
ngham et al., 2002), contributes to the degeneration of
neurons.
Identification of a Multicomponent Genomic
Survival Program
Gene ontology (GO) analysis (http://www.geneontology.
org) helps to identify clusters of functionally related genes
within the activity-regulated gene pools. Because calcium
entry through synaptic NMDA receptors promotes neuro-
nal survival (Hardingham et al., 2002; Ikonomidou et al.,
1999; Lee et al., 2005), we were particularly interested
in genes with a known or putative role in apoptosis or
Neuron
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revealed that genes of the GO term ‘‘apoptosis’’ (GO
6915) were significantly enriched in the activity-regulated
gene pool; the list of 44 activity-regulated genes of the
GO term ‘‘apoptosis’’ is given in Table S2. The results of
a comprehensive GO analysis including a statistical rating
of the relative gene-expression activity for all GO terms us-
ing the standardized difference score (z score) are given in
Table S3.
Inspection of the gene-expression profiles obtained
with Affymetrix microarrays and QRT-PCR analysis of
mRNA levels revealed that a subset of the genes listed
in Table S2 are regulated by calcium entry through synap-
Figure 3. Gene Transcription Is Important for Synaptic NMDA
Receptor-Induced Survival and Extrasynaptic NMDA Recep-
tor-Induced Cell Death
(A) Analysis of growth-factor-withdrawal-induced (indicated as GF)
apoptosis in hippocampal neurons with or without subjecting the neu-
ron to a period of AP bursting (AP) inducing synaptic NMDA receptor-
induced survival in the presence or absence of actinomycin D (ActD).
Actinomycin D was added 10 min before inducing AP bursting.
(B) Analysis of cell death induced by bath application 40 mM glutamate
in the presence or absence of actinomycin D. Actinomycin D was
added 10 min before glutamate bath application.
Bars represent means ± SEM [(A), n = 3; (B) n = 3]. Statistical signifi-
cance was determined by analysis of variance (ANOVA); statistically
significant differences are indicated with asterisks (***p < 0.001).Ntic but not through extrasynaptic NMDA receptors and
thus may play a key role in neuroprotection afforded by
synaptic NMDA receptors (Figure 4). This subset contains
several genes for which a function in the nervous system
was previously unknown. One gene is Btg2 (also known
as Tis21/PC3) (Fletcher et al., 1991), which was first iden-
tified as a phorbol-ester-inducible gene in Swiss 3T3 cells
(Lim et al., 1987). Btg2 is a potentially antiapoptotic gene
that can protect PC12 cells from cell death (el-Ghissassi
et al., 2002; Corrente et al., 2002). A second gene is
Bcl6, a transcriptional repressor that has been implicated
in the pathogenesis of B cell lymphomas (Pasqualucci
et al., 2003). It suppresses expression of p53 and, in B
cell lines, can protect from apoptosis induced by DNA
damage (Phan and Dalla-Favera, 2004; Polo et al.,
2004). Our experiments demonstrate that both genes,
Btg2 and Bcl6, confer robust neuroprotection, particularly
when coexpressed in hippocampal neurons (see below;
Figure 5). Additional components of the genomic pro-sur-
vival program controlled specifically by synaptic NMDA
receptors are Atf3, a member of the ATF/CREB family of
basic region/leucine zipper proteins that has been impli-
cated in the survival of neuronal and nonneuronal cells
(Nakagomi et al., 2003; Janz et al., 2006; S.-J.Z. and
H.B., unpublished data); heat shock protein 70 (Hsp70,
also termedHspa1b), a chaperon with neuroprotective ac-
tivity (Dong et al., 2005); the caspase 8-associated protein
2 (also known as FLASH) (Imai et al., 1999); Tia1 (a mem-
ber of the RNA recognition motif family of RNA-binding
proteins [Forch and Valcarcel, 2001]). FLASH and Tia1
are proapoptotic genes that in contrast to Btg2, Bcl6,
and Atf3 are repressed by synaptic NMDA receptor stim-
ulation (Table S2 and Figure 4). The coordinate expression
of proapoptotic and antiapoptotic genes indicates that the
survival function is implemented in neurons through a
multicomponent system of functionally related genes that
are controlled by calcium signals initiated specifically at
synaptic NMDA receptors. This core survival program
(regulated by synaptic NMDA receptors) may be further
supported by genes that are induced or repressed prefer-
entially (but not exclusively) by the activation of synaptic
NMDA receptors. Such genes include Bdnf and Gadd45
(see Table S2).
Btg2 and Bcl6 Confer Neuroprotection
To investigate a possible neuroprotective potential of Btg2
and Bcl6, we determined their ability to protect hippocam-
pal neurons from apoptosis induced by the withdrawal of
growth and trophic factors or treatment with a low con-
centration of the general protein kinase inhibitor stauro-
sporine (Hardingham et al., 2002). Hippocampal neurons
were infected with a recombinant adeno-associated virus
(rAAV) carrying myc-tagged Btg2 (rAAV-Btg2-Myc), myc-
tagged Bcl6 (rAAV-Bcl6-Myc), or hrGFP (humanized
Renilla reniformis green fluorescent) (rAAV-hrGFP) (Fig-
ure 5A). Expression of the proteins was assessed in immu-
noblots using antibodies to the myc-tag of Btg2 and Bcl6
or antibodies to hrGFP (Figure 5B); infection rates wereeuron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 553
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aptic and Extrasynaptic NMDA Recep-
tors of Genes Involved in Cell Survival
and Cell Death
Affymetrix gene chip profiles and QRT-PCR
analysis are shown. Hippocampal neurons
were left unstimulated or were treated for 2
and 4 hr either with 50 mM bicuculline (to induce
AP bursting) in the presence or absence of MK-
801 (10 mM) or with glutamate (20 mM) in the
presence or absence of APV (500 mM). Bars
represent means ± SEM (GeneChip, n = 3;
QRT-PCR, n = 4).determined immunocytochemically and ranged from
80%–95% of the viable neurons (data not shown). In unin-
fected hippocampal neurons and in neurons infected with
rAAV-hrGFP, the percentage of apoptotic cells increased
from 14% ± 1% and 17% ± 1%, respectively, in control
condition to 53% ± 1% and 55% ± 2%, respectively, fol-
lowing 36 hr of staurosporine treatment (Figure 5C); a sim-
ilar increase in the percentage of apoptotic cells (from
about 25% in control condition to about 50%) was ob-
served after 72 hr of growth-factor withdrawal (Figure 5D).
Expression of Btg2 or Bcl6 alone reduced staurosporine-
induced cell death to 30% ± 2% and 43% ± 2%, respec-
tively, and reduced growth-factor-withdrawal-induced
cell death to 28% ± 3% and 31% ± 1%, respectively (Fig-
ures 5C and 5D). The most dramatic neuroprotection was
obtained when Btg2 and Bcl6 were coexpressed in the
neurons; under these conditions, inhibition of apoptosis
induced by staurosporine treatment and by growth-factor
withdrawal was 77% ± 7% and 90% ± 7%, respectively
(Figures 5C–5E). We also determined whether Btg2 and
Bcl6 can block the activation of caspases, which is asso-
ciated with apoptotic cell death (Yuan and Yankner, 2000).
Immunoblot experiments using an antibody to the acti-
vated form of caspase 3 revealed that indeed in neurons554 Neuron 53, 549–562, February 15, 2007 ª2007 Elsevier Incinfected with rAAV-Btg2-Myc or rAAV-Bcl6-Myc but not
in neurons infected with rAAV-hrGFP, the activation of
caspases following staurosporine treatment was inhibited
(Figure 5F). Again, the strongest inhibition of caspase ac-
tivation was observed in neurons expressing both Btg2
and Bcl6 (Figure 5F). These results indicate that Btg2 or
Bcl6, particularly when coexpressed, can confer a robust
neuroprotection.
We next investigated whether Btg2 and Bcl6 contribute
to activity-dependent survival afforded by AP bursting and
activation of the synaptic NMDA receptor (Hardingham
et al., 2002; Lee et al., 2005; Papadia et al., 2005). RNA in-
terference (RNAi) was used to inhibit expression of Btg2
and Bcl6. Short hairpin RNA (shRNA) designed to target
the mouse Btg2 and Bcl6 mRNA was inserted down-
stream of the U6 promoter of a rAAV vector. The resulting
rAAV, termed rAAV-Btg2-RNAi and rAAV-Bcl6-RNAi, also
harbors an expression cassette for hrGFP. To control for
nonspecific effects of infections with rAAVs carrying an
expression cassette for shRNAs, a rAAV was used that
contains a negative control shRNA (rAAV-control-RNAi),
which has no significant sequence similarity to the mouse,
rat, or human genome. Analysis of hrGFP expression
allowed us to assess infection rates, which ranged from.
Neuron
Decoding NMDA Receptor SignalingFigure 5. Expression of Btg2 and Bcl6
in Hippocampal Neurons Promotes
Survival
(A) Schematic drawing of the structure of the
viral vector used to generate recombinant
adeno-associated virus.
(B) Immunoblot analysis of uninfected hippo-
campal neurons or hippocampal neurons in-
fected with rAAV-hrGFP, rAAV-Btg2-Myc, or
rAAV-Bcl6-Myc. Btg2 and Bcl6 are myc-
tagged and were detected with the 9E10 anti-
body; hrGFP was detected with an antibody
to hrGFP. A representative example of three in-
dependent experiments is shown.
(C–E) Growth-factor-withdrawal-induced (GF)
(C) and staurosporine-induced (D) apoptosis in
uninfected hippocampal neurons and in hippo-
campal neurons infected with rAAV-hrGFP,
rAAV-Btg2-Myc, rAAV-Bcl6-Myc, or with a mix-
ture of rAAV-Btg2-Myc and rAAV-Bcl6-Myc.
Stau, staurosporine. The inhibition by Btg2
and Bcl6 overexpression of growth-factor-
withdrawal- and staurosporine-induced apo-
ptosis is summarized in (E).
Bars represent means ± SEM (A), n = 3; (B) n = 3.
Statistical significance was determined by
analysis of variance (ANOVA); statistically sig-
nificant differences are indicated with asterisks
(*p < 0.05, ***p < 0.001).
(F) Immunoblot analysis using antibody to the
activated form of caspase 3 in uninfected hip-
pocampal neurons or hippocampal neurons
infected with rAAV-hrGFP, rAAV-Btg2-Myc, or
rAAV-Bcl6-Myc. A representative example is
shown in the upper panel; quantitative analysis
of three independent experiments is shown in
the lower panel.80% to 95% of the neuron population (data not shown).
QRT-PCR analysis revealed that in neurons infected with
rAAV-Btg2-RNAi or rAAV-Bcl6-RNAi but not in neurons
infected with rAAV-control-RNAi, induction of Btg2 and
Bcl6, respectively, was inhibited (Figure 6A). Given the
neurotropism of rAAVs used in the study (Xu et al.,
2001), the results also indicate that the induction of Btg2
and Bcl6 occurs in hippocampal neurons and not in glial
cells.
To assess activity-dependent survival, apoptotic cells
were counted after treatment with staurosporine. In neu-
rons without previous periods of neuronal activity, stauro-
sporine increased the percentage of apoptotic cells to
about 50%–60% (Figure 6B). Upon subjecting the neu-
rons to a period of 16 hr of AP bursting prior to staurospor-
ine exposure, the induced cell death is almost completely
blocked (Figure 6B). This neuroprotection, which is acti-
vated by the synaptic NMDA receptor (Hardingham
et al., 2002; Lee et al., 2005; Papadia et al., 2005), was ob-
served in uninfected neurons and in neurons infected with
rAAV-control-RNAi but not in neurons infected with rAAV-
Btg2-RNAi. This indicates that Btg2 is an important com-
ponent of the synaptic NMDA receptor-induced genomic
survival program. In cells infected with rAAV-Bcl6-RNAi,Nwe observed cell-death rates that even in control condi-
tion (i.e., without staurosporine) already reached levels
higher than normally seen only after exposure to death-
inducing stimuli (Figure 6B). Staurosporine did not further
increase the percentage of dead neurons (Figure 6B). This
finding indicates that Bcl6 is also an important player in the
survival of neurons. Since Bcl6 is a transcriptional repres-
sor (Phan and Dalla-Favera, 2004), one function of Bcl6 in
neurons may be to repress proapoptotic genes.
Nuclear Calcium Signaling Controls Survival
Gene Expression
Recent experiments revealed that nuclear calcium may be
a key signal in the induction of survival programs (Hardi-
ngham et al., 2002; Papadia et al., 2005). We therefore in-
vestigated the possibility that Btg2 and Bcl6 belong to the
class of nuclear calcium-regulated genes involved in ac-
tivity-dependent survival. To interfere with nuclear calcium
signaling, we expressed in hippocampal neurons the cal-
modulin (CaM)-binding peptide, CaMBP4 (Wang et al.,
1995). CaMBP4 is a nuclear protein that consists of four
repeats of the M13 calmodulin-binding peptide derived
from the myosin light chain kinase; it binds to and inacti-
vates the nuclear calcium/CaM complex (Wang et al., 1995).euron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 555
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synaptic activity-evoked CREB-mediated transcription
and prevents the induction by neuronal activity of a geno-
mic neuroprotective program (Papadia et al., 2005). Using
rAAV-mediated gene transfer, we obtained expression of
CaMBP4 or hrGFP in 80%–95% of the viable neurons
(Figures 7A and 7B). The regulation of expression of
Btg2 and Bcl6 was assessed using QRT-PCR analysis
(Figure 7C). We found that compared to control (i.e., non-
infected neurons or neurons infected with rAAV-hrGFP),
induction of Btg2 transcription by AP bursting was dra-
matically reduced in neurons infected with rAAV-CaMBP4
(Figure 7C). In contrast, the expression of several other
genes, which are not regulated by calcium signaling
pathways in hippocampal neurons, was not affected by
Figure 6. Btg2 and Bcl6 Are Necessary for Neuronal Survival
(A) QRT-PCR analyses illustrating the blockade of activity-dependent
induction of Btg2 and Bcl6 expression using RNAi. Uninfected hippo-
campal neurons or hippocampal neurons infected with rAAVs express-
ing either a control shRNA (rAAV-control-RNAi) or shRNAs that target
Btg2 (rAAV-Btg2-RNAi) or Bcl6 (rAAV-Btg2-RNAi) were stimulated
for 4 hr with 50 mM bicuculline to induce AP bursting or were left
unstimulated.
(B) Analysis of the role of Btg2 and Bcl6 in neuronal survival. Uninfected
hippocampal neurons or hippocampal neurons infected with rAAV-
control-RNAi, rAAV-Btg2-RNAi, or rAAV-Bcl6-RNAi were left untreated
or were treated for 16 hr with bicuculline (50mM) in the presence of 4-AP
(250 mM) to induce AP bursting and synaptic NMDA receptor-depen-
dent neuronal survival. Subsequently, apoptosis induced by stauro-
sporine (Stau) treatment was analyzed. Expression of rAAV-Btg2-
RNAi but not rAAV-control-RNAi eliminates neuroprotection afforded
by synaptic activity. Expression of rAAV-Bcl6-RNAi dramatically
increased cell death in control condition.
Bars represent means ± SEM [(A), n = 3; (B) n = 4]. Statistical signifi-
cance was determined by ANOVA; statistically significant differences
are indicated with asterisks (***p < 0.001).556 Neuron 53, 549–562, February 15, 2007 ª2007 Elsevier Incinfection of the hippocampal neurons with AAV-CaMBP4.
These genes include fibroblast growth factor 1, peroxi-
some proliferator-activated receptor g, coactivator 1 a,
DNA (cytosine-5-)-methyltransferase 1, and glucuroni-
dase, b (data not shown). These results indicate that nu-
clear calcium signaling is critical for activity-dependent
regulation of Btg2 expression. Nuclear calcium signaling
is also important for Bcl6 induction by AP bursting,
although compared to Btg2, Bcl6 was only moderately
induced by synaptic activity (Figure 7C).
Extrasynaptic NMDA Receptors Induce Expression
of CLCA1 that Kills Neurons
Extrasynaptic NMDA receptors fail to activate the nuclear
calcium-regulated core survival program but instead cou-
ple to expression of a pro-death gene. Gene ontology
queries have drawn our attention to Clca1. CLCA1 is a pu-
tative calcium-activated chloride channel (Elble and Pauli,
2001), although the precise nature of this protein remains
to be determined (Gibson et al., 2005; Pawlowski et al.,
2006). CLCA1 shows a very unusual, unprecedented
mode of regulation: Clca1 is induced by calcium entry
through extrasynaptic NMDA receptors, but not by cal-
cium entry through synaptic NMDA receptors (Figure 8A.
In tumor cells, expression of CLCA1 has been linked to
cell-cycle arrest and the induction of proapoptotic path-
ways (Elble and Pauli, 2001). This raises the possibility
that an increase in CLCA1 expression following activation
of extrasynaptic NMDA receptors promotes neuronal cell
death. To test this hypothesis, we transfected hippocam-
pal neurons with an expression vector for CLCA1 and
followed the fate of the neurons. We found that CLCA1-
expressing neurons undergo cell death (Figures 8B and
8C). We also attempted loss-of-function experiments us-
ing Clca1 RNAi. Although we succeeded in generating
an shRNA that inhibited Clca1 expression following
bath-glutamate stimulation by about 75%, this reduction
of Clca1 expression did not protect the neurons from glu-
tamate toxicity (data not shown). Therefore, an essential
role for CLCA1 in excitotoxicity remains to be shown. Nev-
ertheless, Clca1, the first gene identified that is induced
specifically by extrasynaptic NMDA receptors, is sufficient
to kill neurons and is thus a likely part of the genomic death
program activated by extrasynaptic NMDA receptors.
DISCUSSION
Neuronal Activity-Regulated Genes
The development of DNA microarrays and bioinformatics
tools makes it possible to obtain whole-genome expres-
sion profiles and to relate them to specific biological func-
tions. This approach has been successful in the study of
various human diseases including cancer and diabetis
mellitus (DeRisi et al., 1997; Hughes et al., 2000; Lamb
et al., 2003; Mootha et al., 2003). Here we used expression
profiling to survey the genome for transcripts whose levels
are altered in neurons after electrical activation and stim-
ulation of the calcium signaling pathway. We focused on.
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Decoding NMDA Receptor SignalingFigure 7. Nuclear Calcium Signaling
Controls Activity-Dependent Regulation
of Btg2 and Bcl6
(A and B) Immunocytochemical (A) and immu-
noblot analysis (B) of hippocampal neurons in-
fected with rAAVs expressing CaMBP4 or
hrGFP. CaMBP4 is Flag-tagged and was de-
tected with an antibody to the Flag; hrGFP
was detected with an antibody to hrGFP. (A) A
representative example of three independent
experiments is shown. (B) Nuclei of cells were
counterstained with Hoechst 33258. Represen-
tative images are shown. Scale bar is 15 mm.
(C) Blockade of activity-dependent induction of
Btg2 and Bcl6 expression in neurons express-
ing CaMBP4. Uninfected hippocampal neurons
or hippocampal neurons infected with rAAVs
expressing either CaMBP4 or hrGFP as control
were treated for 2 and 4 hr with bicuculline
(50 mM) to induced AP bursting or were left
unstimulated. Expression of Btg2 and Bcl6
was analyzed by QRT-PCR; bars represent
means ± SEM (n = 3).the importance of the site of calcium signal initiation, in
particular the NMDA receptor, in the specification of the
genomic responses. A comprehensive list of 959 activ-
ity-regulated genes was generated. A large fraction of
the genes were regulated in an NMDA receptor-depen-
dent manner. However, several hundred genes were
induced or repressed by electrical activity even when
NMDA receptors were blocked pharmacologically. The
transcriptional responses of those genes may be triggered
by calcium signals generated by opening of L-type
voltage-gated calcium channels. Calcium flux through L-
type calcium channels is known to stimulate transcription
both via the SRE and the CRE (Bading et al., 1993); target
genes of calcium signaling pathways include many imme-
diate-early genes and the neurotrophin Bdnf (Hardingham
et al., 2002; Bading et al., 1995; Ghosh et al., 1994). It is
conceivable that also the activation of metabotropic gluta-
mate receptors contributes to gene regulation upon APbursting or glutamate bath application. Further expres-
sion profiling studies are required for a detailed analysis
of NMDA receptor-independent transcription regulatory
mechanisms.
Calcium Entry Site-Specific Genomic Responses
Our finding that calcium entry through synaptic and extra-
synaptic NMDA receptors evokes different transcriptional
responses may not be unexpected given the known differ-
ences of these spatially distinct entry sites in the control of
CREB function. However, the strikingly small degree to
which the target gene pools overlap is surprising. More-
over, even those genes that are not exclusively regulated
by one calcium entry site (i.e., 7 out of 149 genes in the
case of synaptic NMDA receptors and 8 out of 20 genes
in the case of extrasynaptic NMDA receptors; see Figure 2)
showed large quantitative differences in their regulation
by synaptic and extrasynaptic NMDA receptors. TheseNeuron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 557
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Decoding NMDA Receptor SignalingFigure 8. Clca1, a Pro-Death Gene In-
duced by Extrasynaptic NMDA Receptor
(A) Extrasynaptic NMDA receptors induce ex-
pression of Clca1; Affymetrix gene chip profiles
and QRT-PCR analysis are shown. Hippocam-
pal neurons were left unstimulated or were
treated for 2 and 4 hr either with 50 mM bicucul-
line (to induce AP bursting) in the presence or
absence of MK-801 (10 mM) or with glutamate
(20 mM) in the presence or absence of APV
(500 mM).
(B) Overexpression of CLCA1 induces hippo-
campal neuron cell death. Examples of photo-
micrographs of hippocampal neurons trans-
fected with an expression vector for EGFP
together with either an expression vector for
CLCA1 or vector control are shown. Hippo-
campal neurons expressing CLCA1 showed
typical signs of cell death; vector-transfected
neurons remained healthy. The arrows indicate
healthy (left) and apoptotic (right) neurons.
Scale bar is 50 mm.
(C) Quantitative analysis of cell death of hippo-
campal neurons transfected with an expres-
sion vector for EGFP together with either an ex-
pression vector for CLCA1 or vector control.
The percentage of apoptotic nuclei within the
population of EGFP-positive neurons was
measured 3 days after transfection. Bars repre-
sent means ± SEM (n = 3). Statistical signifi-
cance was determined by analysis of variance
(ANOVA); statistically significant differences
are indicated with asterisks (*p < 0.05).results underscore the ability of calcium, the universal
messenger in activity-dependent transcription, to act as
a versatile carrier of information that, depending on its
site of action, initiates qualitatively and quantitatively dis-
tinct transcriptional programs.
Differential gene regulation by synaptic and extrasynap-
tic NMDA receptors is most likely due to differences in the
local, near-NMDA receptor signaling. Many components
of the NMDA receptor signaling complex have been iden-
tified (Husi et al., 2000; Sheng and Kim, 2002), yet it is un-
clear which proteins associate specifically with synaptic
versus extrasynaptic NMDA receptors. It is possible that
one difference is in the control of protein phosphatase
(PP) 1 function. PP1 is the principal CREB phospho-serine
133 phosphatase (Hagiwara et al., 1992) and thus a likely
mediator of the CREB shut-off pathway triggered by extra-
synaptic NMDA receptors (Sala et al., 2000). In addition,
the action of a phosphatase (perhaps PP1) may also be re-
sponsible for nuclear localization of class II HDACs that is
promoted by bath-glutamate treatment stimulating extra-
synaptic NMDA receptors (Chawla et al., 2003). PP1 is558 Neuron 53, 549–562, February 15, 2007 ª2007 Elsevier Ina known target of a calcium signaling pathway acting via
calcineurin and inhibitor 1 (Bito et al., 1996). Alternatively,
a possible regulation of PP1 by extrasynaptic NMDA re-
ceptors could involve a PP1 regulatory subunit (Bollen,
2001) that targets the enzyme to specific substrates
such as CREB.
Coordinate Expression of Functionally
Related Genes
Our finding that calcium entry through synaptic NMDA
receptors induced several antiapoptotic genes and re-
presses several proapoptotic genes indicates that the
known prosurvival activity of the synaptic NMDA receptor
results from a coordinate change in expression of a set of
functionally related genes. In this study we have analyzed
two of these genes, Btg2 and Bcl6. Btg2 may function as
a nuclear protein involved in the regulation of gene tran-
scription and inhibition of cell-cycle progression at the
G1 checkpoint (Prevot et al., 2000; Tirone, 2001; Park
et al., 2004). Btg2 expression can also be induced by
a p53-dependent mechanism that may be relevant toc.
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1996). The regulation by electrical activity and calcium sig-
naling pathways in postmitotic neurons was previously not
known, although transient expression of Btg2 has been
reported during neurogenesis in precursor cells of the
telencephalic ventricular/subventricular zone (Iacopetti
et al., 1994, 1999; Haubensak et al., 2004) and following
neuroprotective ischemic preconditioning in the spinal
cord (Carmel et al., 2004). Its pro-survival activity was first
demonstrated in NGF differentiated PC12 cells (el-Ghis-
sassi et al., 2002; Corrente et al., 2002). Our experiments
indicate that the induction of Btg2 expression following
calcium entry through synaptic NMDA receptors is a signif-
icant part of a transcriptional program that mediates activ-
ity-dependent survival.
Bcl6, a transcriptional repressor, has been studied in
the immune system, where it is necessary for germinal-
center formation and involved in the pathogenesis of B
cell lymphomas (Phan and Dalla-Favera, 2004; Polo
et al., 2004). Among the targets of Bcl6 are the cell-
cycle-arrest gene Cdkn1a and the tumor suppressor p53
(Phan and Dalla-Favera, 2004; Phan et al., 2005). Through
suppression of Cdkn1A, Bcl6 appears to facilitate the
proliferative response of germinal center cells during the
normal immune response (Phan et al., 2005). The reduc-
tion of p53 expression by Bcl6 in germinal center B cells
enables those cells to tolerate physiological DNA breaks
required for the recombination of immunoglobulin genes
and somatic hypermutation without activating an apopto-
tic response (Phan and Dalla-Favera, 2004; Polo et al.,
2004). One possible function of the here described upre-
gulation of Bcl6 expression following the stimulation of
synaptic NMDA receptors in neurons may be to antago-
nize increases in p53 production associated with DNA
damage or other forms of cellular stress (Culmsee and
Mattson, 2005), thereby preventing or attenuating p53-
induced apoptosis. In addition, DNA strand breaks and re-
combination events could conceivably take place in neu-
rons physiologically (Chun et al., 1991; Gao et al., 1998)
as a result of neuronal activity and NMDA receptor activa-
tion, and similar to the situation in B cells, Bcl6 may sup-
press the apoptotic response triggered by those events.
Genomic Events Linked to Extrasynaptic
NMDA Receptors
Compared to the large number of genes induced (and re-
pressed) by synaptic NMDA receptors, a set of only 12
genes was specifically regulated by glutamate bath appli-
cation and the stimulation of extrasynaptic NMDA recep-
tors. This was not unexpected because extrasynaptic
NMDA receptors, in contrast to the synaptic NMDA recep-
tors, couple to a CREB shut-off pathway and lead to im-
port of class II HDACs (that cause repression of gene tran-
scription) into the nucleus (Hardingham et al., 2002; Sala
et al., 2000; Chawla et al., 2003). The mechanism through
which extrasynaptic NMDA receptors activate this set of
genes remains to be investigated. It may involve the coac-
tivator CBP, whose transcription-activating function isNrobustly induced by bath-glutamate treatment of hippo-
campal neurons (Hardingham et al., 1999; Hu et al.,
1999), and/or transcription factors that interact with the
SRE (Bading et al., 1993). However, both CBP and the
SRE can also be activated by calcium entry through syn-
aptic NMDA receptors, leaving unexplained the observed
differences in the genomic responses triggered by synap-
tic versus extrasynaptic NMDA receptors. A more compli-
cated scenario (e.g., a decrease of one or several CREB-
regulated genes leads to upregulation of other genes) or
a posttranscriptional process may underlie the gene-
expression events specifically induced by extrasynaptic
NMDA receptors.
The stimulation of extrasynaptic NMDA receptors can
initiate cell death (Hardingham and Bading, 2003; Hardi-
ngham et al., 2002), which is at least in part mediated by ex-
trasynaptic NMDA receptor-induced transcription. A geno-
mic death program may involve Clca1, a pro-death gene
specifically induced by extrasynaptic NMDA receptors.
Nuclear Calcium: On-Switch for Neuroprotective
Genomic Program
CREB, a key target of the nuclear calcium signaling path-
way (Hardingham et al., 1997), is a robust activator of gene
expression following calcium entry through synaptic
NMDA receptors (Hardingham et al., 2001) and an impor-
tant mediator of a nuclear calcium-regulated neuroprotec-
tive genomic program (Hardingham et al., 2002; Papadia
et al., 2005; Walton and Dragunow, 2000; Lonze and
Ginty, 2002). Mice containing targeted disruptions of
both the Creb gene and its close relative Crem show ex-
tensive cell death in the brain, underscoring a central
role of these transcription factors in neuronal survival
(Mantamadiotis et al., 2002). In this study we identified
a set of survival-promoting genes that are specifically in-
duced by calcium entry through synaptic NMDA recep-
tors. We could show that at least two of these genes,
Btg2 and Bcl6, are controlled by nuclear calcium signaling
and when overexpressed in hippocampal neurons confer
robust neuroprotection. Transcription factors and path-
ways controlling the Bcl6 promoter have not been charac-
terized in detail, although analysis of the Bcl6 50 regulatory
region revealed the presence of a CRE (50-CGACGTCA-30)
in the 50 UTR. However, the functional importance of this
site remains to be investigated.Btg2 is a known CREB tar-
get: it contains a CRE in its proximal promoter (Fletcher
et al., 1991), and chromatin immunoprecipitation assays
indicate that CREB occupies the Btg2 promoter in vivo
(Impey et al., 2004). Inspection of the CREB regulon (Im-
pey et al., 2004) and CREB target gene database queries
(http://natural.salk.edu/creb/) (Zhang et al., 2005) re-
vealed that many genes of the NMDA receptor-regulated
survival program are known or putative CREB targets
(see Table S2). Although it remains to be studied precisely
how calcium signaling controls the expression of those
genes, given the possible involvement of CREB, it seem
likely that an increase in the nuclear calcium concentration
serves as the on-switch for many of them. Thus, nucleareuron 53, 549–562, February 15, 2007 ª2007 Elsevier Inc. 559
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Decoding NMDA Receptor Signalingcalcium may prove to be the master regulator of a neuro-
protective genomic program.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details of whole-
genome transcription profiling, QRT-PCR, production of rAAV, and
assessment of cell death.
Hippocampal Neurons
Hippocampal neurons from new-born C57Black mice were cultured in
Neurobasal media (Invitrogen, Gaithersburg, MD) containing 1% rat
serum and B27 (Invitrogen). The procedure used to isolate and culture
hippocampal neurons has been described (Bading and Greenberg,
1991; Bading et al., 1993). Stimulations were done after a culturing
period of 10–12 days.
Whole-Genome Transcription Profiling
DNA microarray analysis was done using Affymetrix GeneChip Mouse
Expression Set 430 (MOE 430A and MOE 430B). See Supplemental
Experimental Procedures for details.
Recombinant Adeno-Associated Virus
The vectors used to construct and package rAAVs have been de-
scribed previously (Klugmann et al., 2005). Hippocampal neurons
were infected with rAAVs at 4 days in vitro (DIV). See Supplemental
Experimental Procedures for details.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/53/4/549/DC1/.
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